Phase 2 Trial of Paclitaxel, 13-cis Retinoic Acid, and Interferon Alfa-2b in the Treatment of Advanced Stage or Recurrent Cervical Cancer

Authors

Keywords

Journal

Volume 24, Issue 9, Pages 1636-1641

Publisher

Ovid Technologies (Wolters Kluwer Health)

Online

2014-10-11

DOI

10.1097/igc.0000000000000258

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started